New circumstances in gynecologic oncology have pushed us to develop new educational programs that meet the real needs of experienced professionals, so that they can incorporate new advances into their daily practice"

The fact that the ovarian cancer mortality rate is so high makes the disease a problem for women and a public health risk.

As most of these ovarian tumors are detected in advanced stages of the disease, the survival rate is only about 30% of cases. Those from the ovaries and fallopian tubes have a peculiarity: they are the tumors with the greatest influence and variability in prognosis with respect to the way they are treated. This makes a thorough understanding of the disease and the correct application of treatments the basis for increasing the survival and cure rates of patients with the disease.

This program is oriented to achieve the updating of the procedures of action for the patient with ovarian cancer. In addition, thanks to this program the student will be able to conceptually manage both the bases of tumor biology and specific medical treatments, as well as the rest of the aspects related to the diagnosis and treatment of ovarian cancer in women.

This Postgraduate Diploma will allow you to learn about the latest advances in Ovarian Cancer, using the latest educational technology"

This postgraduate diploma in Ovarian Cancer contains the most complete and up-to-date scientific program on the market. Its most notable features are:  

• The examination of clinical cases, recorded with POV (Point of View) systems from different angles, presented by experts in gynecology and other disciplines 
• The graphic, schematic, and practical contents with which they are created, provide scientific and practical information on the disciplines that are essential for professional practice 
• Presentation of practical workshops on procedures and techniques. 
• An algorithm-based interactive learning system for decision-making in the clinical situations presented throughout the course. 
• Action protocols and clinical practice guidelines, which cover the most important latest developments in this specialist area. 
• All of this will be complemented by theoretical lessons, questions to the expert, debate forums on controversial topics, and individual reflection assignments. 
• Special emphasis on test-based medicine and research methodologies in oncology 
• Content that is accessible from any fixed or portable device with an Internet connection 

This postgraduate diploma may be the best investment you can make when selecting a refresher program, for two reasons: in addition to updating your knowledge on Ovarian Cancer you will obtain a postgraduate diploma issued by TECH Global University"

The teaching staff includes a team of renowned gynecologists and oncologists, who bring their professional experience to this program, in addition to recognized specialists belonging to leading scientific societies.

The multimedia content developed with the latest educational technology will provide the professional with situated and contextual learning, i.e. a simulated environment that will provide an immersive training program to train in real situations.

This program is designed around Problem-Based Learning, whereby the specialist must try to solve the different professional practice situations that arise throughout the postgraduate diploma. For this reason, you will be assisted by an innovative, interactive video system created by renowned and experienced experts in the field of gynecology and oncology with extensive teaching experience.

Incorporate the latest developments in the approach to Ovarian Cancer into your daily practice and improve the prognosis of your patients"

Seize this opportunity and take the next step to get up to date on the latest developments in ovarian cancer treatments"

The main objective is oriented to allow the incorporation of the advances that are taking place in the approach to ovarian oncological processes in women, ensuring that the specialist can update their knowledge in a practical way, with the latest educational technology and adapting the educational process to their real needs.

This postgraduate diploma will provide you with a sense of assurance when making decisions about Ovarian Cancer, and will help you grow both professionally”

General Objective

• Update the specialist's knowledge of the procedures and techniques used in Ovarian Cancer, incorporating the latest advances in the discipline to increase the quality of their daily medical practice

Specific Objectives

Module 1. Biological Basis of Cancer 

• Recognize and understand the molecular bases of carcinogenesis as well as its development and metastasis production 
• Define the basis of cellular growth regulation
• Understand the role of carcinogens in the formation of genital cancer
• Gain up-to-date knowledge of cancer genetics
• Understand the cellular mechanisms of programed cell death and apoptosis and their relationship and activity with malignant pathology 
• Interpret the mechanisms of cancer production and distant metastatis at a molecular level
• Identify the origins of genetic alterations that provoke cancer
• Identify the epigenetic changes and oncogenes related with genital tract tumor pathology 
• Explain the mechanisms tumor neoformation in blood vessels
• Recognize respiratory symptomatology, such as that caused by pleural effusion, in the treatment of gynecologic cancer

Module 2. Basis of Chemotherapy Treatment, Adverse Effects and New Therapies 

• Identify the essentials for the use of chemotherapy in gynecologic oncology as well as adverse effects and complications 
• Identify the basic factors that are involved in chemotherapy treatment
• Highlight the influence of chemotherapy in the cellular cycle
• Identify the action mechanisms of antineoplastic agents
• Recognize the mechanisms for the resistance of medical treatments in gynecologic cancer
• Gain up-to-date knowledge of toxicity and side effects 
• Review the available antineoplastic drugs and their characteristics
• Identify cases in which patient observation can be used without using adjuvant treatment
• Understand the role of new tests such as positron emission tomography for cervical cancer 
• Evaluate the role of tumor markers such as SCC
• Update the role of laparoscopy in the performance of radical hysterectomy and para-aortic staging lymphadenectomy for non-early tumor stages 
• Evaluate the use of medical and surgical therapy in mestastatic, recurrent or persistent illness
• Study and analyze the postoperative care of patients to identify any complications early on
• Appropriately assess the role of chemotherapy in gestational trophoblastic disease 
• Manage the progression of pelvic tumor disease in the most effective way

Module 3. Ovarian Cancer I

• Identify patients at risk of ovarian cancer and perform a precise preoperative diagnosis
• Review the epidemiology and etiopathogenesis of ovarian and fallopian tube cancer
• Review the possibilities of screening by ultrasound and the tumor markers for the early detection of ovarian cancer
• Establish the new criteria for pathological and molecular classification of ovarian cancer
• Evaluate the different clinical manifestations, highlighting the value of ultrasound, magnetic resonance imaging and scanning in the diagnosis of ovarian cancer
• Analyze the role of tumor serological markers CA125, CA19.9, CEA, HE4 and other rare tumor serological markers in ovarian cancer 
• Specifically analyze the role of complete cytoreduction and its prognostic implications 
• Analyze the role of interval surgery in ovarian cancer and establish the most appropriate adjuvant chemotherapy steps and biological treatments for each case
• Identify the possibilities available for the follow-up of patients with ovarian cancer
• Analyze the controversies on the management of ovarian and fallopian tube cancer

Module 4. Ovarian Cancer II

• Apply the most appropriate surgical or chemotherapy treatment for each case of ovarian cancer
• To evaluate STIC tubal lesions as precursors of ovarian cancer
• Gain up-to-date knowledge on hereditary-familial ovarian cancer and new predisposing genetic mutations
• Indicate the distinct pathological types of ovarian and fallopian tube cancer and relate them to the different diagnostic tests for studying the extension and initial diagnosis of each one
• Classify the different types of ovarian cancer according to the FIGO classification and determine the general surgical procedures of approach
• Evaluate when a patient should preferentially receive neoadjuvant chemotherapy for ovarian cancer
• Analyze the role of radiotherapy and hormone therapy in endometrial cancer
• Review and gain up-to-date knowledge on intraperitoneal chemotherapy treatments and hyperthermic therapy in ovarian and peritoneal cancer

Module 5. Fertility Preservation 

• Determine the different fertility preservation techniques in young patients and their oncological implications 
• Identify the options for preserving fertility in gynecologic cancer, as well as gamete preservation
• Revise the surgical techniques for preserving fertility in each of the cancers affecting the female genital tract
• Update on the management of pregnant patients with gynecologic cancer 
• Review new options for preserving ovarian tissue
• Gain up-to-date knowledge on the current status of uterine transplantation and the most recent results obtained to date

Module 6. Palliative Care and Nutrition

• Study and understand the basis of palliative care and terminal phase of an oncological illness 
• Evaluate the usefulness of PET-CT for the assessment of metabolism in suspected malignant lesions
• Gain up-to-date knowledge of gastrointestinal symptomology
• Identify the distant metastasis and assess how to manage it
• Describe the indications and the surgical technique specific to palliative pelvic exenteration
• Comprehensive care of a dying patient and learning how to help them in the final phase of the disease 
• Study and treat patients with anxiety and depression in a specific way

Make the most of this opportunity and take the next step to get up to date on the latest developments in Ovarian Cancer”